Valeo Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Valeo Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Buy	6,499 +3,806	+141%	+$515K	0.02%	303
2026 Q1	$344K	Hold	2,693	–	–	0.01%	500
2025 Q4	$328K	Buy	+2,693	New	+$309K	0.01%	587
2025 Q1	–	Sell	-9,595	Closed	-$62.1K	–	783
2024 Q4	$62.1K	Buy	+9,595	New	+$930K	﹤0.01%	714
2021 Q2	–	Sell	-466	Closed	-$63K	–	1855
2021 Q1	$63K	Hold	466	–	–	﹤0.01%	779
2020 Q4	$66K	Buy	466 +250	+116%	+$32K	﹤0.01%	691
2020 Q3	$24K	Sell	216 -84	-28%	-$9.42K	﹤0.01%	881
2020 Q2	$34K	Buy	300 +223	+290%	+$22K	﹤0.01%	872
2020 Q1	$6K	Buy	+77	New	+$6.82K	﹤0.01%	1271
2019 Q3	–	Sell	-300	Closed	-$26K	–	1688
2019 Q2	$26K	Sell	300 -1,225	-80%	-$104K	﹤0.01%	779
2019 Q1	$138K	Hold	1,525	–	–	0.02%	354
2018 Q4	$109K	Hold	1,525	–	–	0.02%	358
2018 Q3	$120K	Hold	1,525	–	–	0.02%	360
2018 Q2	$144K	Buy	1,525 +950	+165%	+$87.3K	0.02%	340
2018 Q1	$50K	Sell	575 -625	-52%	-$57.1K	0.01%	490
2017 Q4	$102K	Buy	+1,200	New	+$101K	0.02%	338

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Valeo Financial Advisors's XBI Position: Q2 2026 in Review

Valeo Financial Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 141% in Q2 2026, buying an estimated $515K and bringing the position to 6,499 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #303.

Valeo Financial Advisors first reported a position in XBI in Q4 2017 and has held it in 16 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Valeo Financial Advisors held 6,499 shares of State Street SPDR S&P Biotech ETF worth $1.03M as of Q2 2026.
Valeo Financial Advisors bought 3,806 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $515K.
State Street SPDR S&P Biotech ETF made up 0.02% of Valeo Financial Advisors's portfolio in Q2 2026, its #303 holding.
Valeo Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 16 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.